APA (7th ed.) Citation

A, T., M, V., T, I., Y, O., S, S., K, T., . . . K, N. (2025). Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: A randomised placebo-controlled mechanistic trial (FIVE-STAR). Cardiovascular diabetology, 24(1), 454. https://doi.org/10.1186/s12933-025-03014-x

Chicago Style (17th ed.) Citation

A, Tanaka, et al. "Effects of Finerenone on Arterial Stiffness and Cardiorenal Biomarkers in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Randomised Placebo-controlled Mechanistic Trial (FIVE-STAR)." Cardiovascular Diabetology 24, no. 1 (2025): 454. https://doi.org/10.1186/s12933-025-03014-x.

MLA (9th ed.) Citation

A, Tanaka, et al. "Effects of Finerenone on Arterial Stiffness and Cardiorenal Biomarkers in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Randomised Placebo-controlled Mechanistic Trial (FIVE-STAR)." Cardiovascular Diabetology, vol. 24, no. 1, 2025, p. 454, https://doi.org/10.1186/s12933-025-03014-x.